In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Arthur Wilde
Arthur Wilde
Arthur Wilde Arthur Wilde

Amsterdam UMC - Location Academic Medical Center, Amsterdam (Netherlands (The))

Specialities : Arrhythmias-General , Basic Science

Biosketch: Arthur A.M. Wilde, born in 1956, got his M.D. at the University of Amsterdam in 1983. After his Ph.D. in 1988, he started his Fellowship training in Cardiology at the Academic Medical Centre, and was registered as such in 1994. Afterwards he specialized in clinical electrophysiology at the Academic Hospital Utrecht. From the Netherlands Heart Association he was awarded a grant as Clinical Established Investigator for five years. In 1999, he became head of the Laboratory of Experimental Cardiology, and in 2003 head of the Department of Clinical and Experimental Cardiology (Academic Medical Centre). He published over 550 SCI papers with, in recent years, a major focus on different aspects of inherited arrhythmia syndromes. In more recent years also genetic factors contributing to sudden cardiac death in the general population became a focus. In 2011 he was appointed as member of the Dutch Academy of Science and in 2012 he received the HRS Distinguished Investigator award.

7 presentations from this speaker

Risk stratification of ventricular arrhythmias in genetic cardiomyopathies.

Event : Webinar 2020

  • Session : EHRA Webinars 2020
  • Speaker : K Haugaa (Oslo,NO), A Wilde (Amsterdam,NL)

Leveraging the cross-border potential: experience from the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-Heart).

Event : ESC Congress 2019

  • Session : Research funding 360: supporting research and researchers in Europe and worldwide
  • Speaker : A Wilde (Amsterdam,NL)
  • Joint session with the European Commission

All you need to know on channelopathies.

Event : Webinar 2018

  • Session : EHRA Webinars 2018
  • Speaker : A Wilde (Amsterdam,NL), C Wolpert (Ludwigsburg,DE)

Beta-blockers for LQT3: Contraindicated, acceptable or the drug of choice?

Event : EHRA 2017

  • Session : Medical treatment of channelopathies: effective and safe?
  • Speaker : A Wilde (Amsterdam,NL)

Genetics of channelopathies

Event : ESC Congress 2017

  • Session : Genetics of sudden cardiac death
  • Speaker : A Wilde (Amsterdam,NL)
  • Joint with the European Society of Human Genetics

When to do genetic testing and family screening in patients with heart failure and cardiomyopathy

Event : ESC Congress 2017

  • Session : Cardiomyopathies: pragmatic approaches
  • Speaker : A Wilde (Amsterdam,NL)

Sudden cardiac death in the young in Europe - State of the art lecture

Event : ESC Congress 2015

  • Session : Cardiac arrest/sudden cardiac death in the young
  • Speaker : A Wilde (Amsterdam,NL)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are